Host-Viral Infection Maps Reveal Signatures of Severe COVID-19 Patients.


Journal

Cell
ISSN: 1097-4172
Titre abrégé: Cell
Pays: United States
ID NLM: 0413066

Informations de publication

Date de publication:
25 06 2020
Historique:
received: 30 03 2020
revised: 16 04 2020
accepted: 01 05 2020
pubmed: 2 6 2020
medline: 11 7 2020
entrez: 2 6 2020
Statut: ppublish

Résumé

Viruses are a constant threat to global health as highlighted by the current COVID-19 pandemic. Currently, lack of data underlying how the human host interacts with viruses, including the SARS-CoV-2 virus, limits effective therapeutic intervention. We introduce Viral-Track, a computational method that globally scans unmapped single-cell RNA sequencing (scRNA-seq) data for the presence of viral RNA, enabling transcriptional cell sorting of infected versus bystander cells. We demonstrate the sensitivity and specificity of Viral-Track to systematically detect viruses from multiple models of infection, including hepatitis B virus, in an unsupervised manner. Applying Viral-Track to bronchoalveloar-lavage samples from severe and mild COVID-19 patients reveals a dramatic impact of the virus on the immune system of severe patients compared to mild cases. Viral-Track detects an unexpected co-infection of the human metapneumovirus, present mainly in monocytes perturbed in type-I interferon (IFN)-signaling. Viral-Track provides a robust technology for dissecting the mechanisms of viral-infection and pathology.

Identifiants

pubmed: 32479746
pii: S0092-8674(20)30568-7
doi: 10.1016/j.cell.2020.05.006
pmc: PMC7205692
pii:
doi:

Substances chimiques

Interferons 9008-11-1

Types de publication

Evaluation Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1475-1488.e12

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

PLoS Pathog. 2017 Mar 22;13(3):e1006292
pubmed: 28328962
Nat Immunol. 2019 Jul;20(7):928-942
pubmed: 31061532
Comput Struct Biotechnol J. 2020 Sep 28;18:2789-2798
pubmed: 33101615
Genome Biol. 2019 Dec 23;20(1):296
pubmed: 31870423
mBio. 2014 May 13;5(3):e00070-14
pubmed: 24825008
Nature. 1980 Feb 14;283(5748):660-2
pubmed: 7354853
Science. 2014 Feb 14;343(6172):776-9
pubmed: 24531970
Emerg Infect Dis. 2003 Sep;9(9):1058-63
pubmed: 14519240
Asian Pac J Allergy Immunol. 2020 Mar;38(1):1-9
pubmed: 32105090
Proc Natl Acad Sci U S A. 2018 Dec 26;115(52):E12363-E12369
pubmed: 30530648
Cell. 2015 May 21;161(5):1202-1214
pubmed: 26000488
Cell. 2017 Jun 15;169(7):1276-1290.e17
pubmed: 28602351
Lancet. 2020 Feb 15;395(10223):470-473
pubmed: 31986257
Elife. 2019 May 15;8:
pubmed: 31090537
Nat Commun. 2018 Feb 12;9(1):619
pubmed: 29434199
Science. 2017 Dec 22;358(6370):1622-1626
pubmed: 29217582
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 May 25;49(2):215-219
pubmed: 32391667
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Emerg Infect Dis. 2020 Jun;26(6):1324-1326
pubmed: 32160148
Genome Biol. 2019 Dec 23;20(1):295
pubmed: 31870412
J Biol Chem. 2009 Dec 11;284(50):34839-48
pubmed: 19833736
Nat Commun. 2018 Jul 10;9(1):2667
pubmed: 29991676
PLoS One. 2015 Mar 30;10(3):e0122839
pubmed: 25822203
Nat Rev Immunol. 2019 Feb;19(2):77-78
pubmed: 30560910
Cell. 2019 Feb 7;176(4):775-789.e18
pubmed: 30595452
JCI Insight. 2019 Feb 21;4(4):
pubmed: 30830861
Cell Syst. 2018 Jun 27;6(6):679-691.e4
pubmed: 29886109
Nat Protoc. 2019 Jun;14(6):1841-1862
pubmed: 31101904
Int J Infect Dis. 2014 Aug;25:45-52
pubmed: 24841931
J Immunol. 2009 Sep 1;183(5):3229-36
pubmed: 19667093
Nat Rev Immunol. 2009 Apr;9(4):246-58
pubmed: 19319143
Adv Virus Res. 2006;66:193-292
pubmed: 16877062
Nat Methods. 2014 Jul;11(7):740-2
pubmed: 24836921
Nat Biotechnol. 2015 Mar;33(3):290-5
pubmed: 25690850
PLoS One. 2015 Mar 27;10(3):e0121491
pubmed: 25816132
Nat Rev Cancer. 2004 Oct;4(10):757-68
pubmed: 15510157
Genome Biol. 2019 Oct 11;20(1):206
pubmed: 31604482
Cell Rep. 2018 Oct 2;25(1):107-117.e3
pubmed: 30282021
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nat Med. 2020 Feb;26(2):171-177
pubmed: 32015555
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Biotechnol. 2018 Jan;36(1):70-80
pubmed: 29227469
Nat Rev Immunol. 2020 Jun;20(6):339-341
pubmed: 32317716
Gastroenterology. 2019 Jan;156(2):418-430
pubmed: 30268785
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Nature. 2018 Aug;560(7720):573-581
pubmed: 30158602
Signal Transduct Target Ther. 2020 Dec 4;5(1):283
pubmed: 33277466
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
J Virol. 2002 Mar;76(5):2375-83
pubmed: 11836415
Nat Biotechnol. 2020 Feb;38(2):147-150
pubmed: 31937974
PLoS Biol. 2018 May 3;16(5):e2003648
pubmed: 29723194
mBio. 2018 Mar 13;9(2):
pubmed: 29535194
Genome Res. 2017 Mar;27(3):491-499
pubmed: 28100584
PLoS Pathog. 2016 Mar 24;12(3):e1005478
pubmed: 27010548
Genome Biol. 2020 Mar 5;21(1):57
pubmed: 32138770
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Database (Oxford). 2016 Dec 26;2016:
pubmed: 28025349
Cell. 2019 Jul 25;178(3):686-698.e14
pubmed: 31257031
Genome Biol. 2015 Dec 10;16:278
pubmed: 26653891
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Commun. 2017 Jan 16;8:14049
pubmed: 28091601
Front Aging Neurosci. 2018 Oct 19;10:324
pubmed: 30405395
J Hepatol. 2019 Dec;71(6):1086-1098
pubmed: 31349000
Cell Syst. 2019 Feb 27;8(2):109-121.e6
pubmed: 30772378

Auteurs

Pierre Bost (P)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel; Systems Biology Group, Department of Computational Biology and USR 3756, Institut Pasteur and CNRS, Paris 75015, France; Sorbonne Universite, Complexite du vivant, Paris 75005, France.

Amir Giladi (A)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Yang Liu (Y)

Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen 518112, Guangdong Province, China.

Yanis Bendjelal (Y)

Systems Biology Group, Department of Computational Biology and USR 3756, Institut Pasteur and CNRS, Paris 75015, France.

Gang Xu (G)

Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen 518112, Guangdong Province, China.

Eyal David (E)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Ronnie Blecher-Gonen (R)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Merav Cohen (M)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Chiara Medaglia (C)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Hanjie Li (H)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Aleksandra Deczkowska (A)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel.

Shuye Zhang (S)

Shanghai Public Health Clinical Center and Institute of Biomedical Sciences, Fudan University, Shanghai 201508, China.

Benno Schwikowski (B)

Systems Biology Group, Department of Computational Biology and USR 3756, Institut Pasteur and CNRS, Paris 75015, France. Electronic address: benno@pasteur.fr.

Zheng Zhang (Z)

Institute for Hepatology, National Clinical Research Center for Infectious Disease, Shenzhen Third People's Hospital, School of Medicine, Southern University of Science and Technology, Shenzhen 518112, Guangdong Province, China. Electronic address: zhangzheng1975@aliyun.com.

Ido Amit (I)

Department of Immunology, Weizmann Institute of Science, Rehovot, Israel. Electronic address: ido.amit@weizmann.ac.il.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH